Exact Mass: 393.1012

Exact Mass Matches: 393.1012

Found 41 metabolites which its exact mass value is equals to given mass value 393.1012, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Q-100035

19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H15N3O6 (393.0961)


   

Rubitecan

(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

C20H15N3O6 (393.0961)


Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone. Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].

   
   

SCHEMBL16724509

SCHEMBL16724509

C23H15N5S (393.1048)


   

10-nitro camptothecin

10-nitro camptothecin

C20H15N3O6 (393.0961)


   
   
   
   

CAY10571

4-[5-(4-fluorophenyl)-2-[4-9methylsulfonyl)phenyl]-1H-imidazol-4-yl]-pyridine

C21H16FN3O2S (393.0947)


   

9-nitro-20(S)-camptothecin

9-nitro-20(S)-camptothecin

C20H15N3O6 (393.0961)


Annotation level-1

   
   

bis[4-(1,1-dimethylethyl)phenyl]-Iodonium

bis[4-(1,1-dimethylethyl)phenyl]-Iodonium

C20H26I+ (393.1079)


   

9-nitrocamptothecin

9-nitrocamptothecin

C20H15N3O6 (393.0961)


   

Fmoc-β-(2-thienyl)-D-alanine

Fmoc-β-(2-thienyl)-D-alanine

C22H19NO4S (393.1035)


   

3-Butyl-1,1,2-trimethyl-1H-benz[e]indolium iodide

3-Butyl-1,1,2-trimethyl-1H-benz[e]indolium iodide

C19H24IN (393.0953)


   

Rosiglitazone HCl

Rosiglitazone HCl

C18H20ClN3O3S (393.0914)


Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

   

FMOC-3-L-ALA(2-THIENYL)-OH

FMOC-3-L-ALA(2-THIENYL)-OH

C22H19NO4S (393.1035)


   

Fmoc-(R)-3-Amino-3-(2-thienyl)-propionic acid

Fmoc-(R)-3-Amino-3-(2-thienyl)-propionic acid

C22H19NO4S (393.1035)


   

7-[(3R)-3-isothiocyanatopyrrolidin-1-yl]-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide

7-[(3R)-3-isothiocyanatopyrrolidin-1-yl]-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide

C16H19N5O5S (393.1107)


   

Fmoc-D-3-Thienylalanine

Fmoc-D-3-Thienylalanine

C22H19NO4S (393.1035)


   

FMoc-L-3-Thienylalanine

FMoc-L-3-Thienylalanine

C22H19NO4S (393.1035)


   
   

Testolone

Testolone

C20H16ClN5O2 (393.0992)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent

   

Codeine methylbromide

Codeine methylbromide

C19H24BrNO3 (393.0939)


   

2-(Biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid

2-(Biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid

C22H19NO4S (393.1035)


   

4-{2-[(4-fluorophenyl)sulfonyl]acetyl}-2,6-dimethylphenyl N,N-dimethylcarbamate

4-{2-[(4-fluorophenyl)sulfonyl]acetyl}-2,6-dimethylphenyl N,N-dimethylcarbamate

C19H20FNO5S (393.1046)


   

4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

C18H20ClN3O3S (393.0914)


   

2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime

2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime

C22H17ClFN3O (393.1044)


   

2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime

2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime

C22H17ClFN3O (393.1044)


   

4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine

4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine

C21H16FN3O2S (393.0947)


   

Isopropyl 6-methyl-2-[(phenylsulfonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

Isopropyl 6-methyl-2-[(phenylsulfonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C19H23NO4S2 (393.1068)


   

3-{[1-(3-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidenemethyl]-amino}-2-methyl-3H-quinazolin-4-one

3-{[1-(3-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidenemethyl]-amino}-2-methyl-3H-quinazolin-4-one

C20H16ClN5O2 (393.0992)


   

8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one

8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one

C20H15N3O6 (393.0961)


   

2-[(3-cyano-4-phenyl-6-thiophen-2-yl-2-pyridinyl)thio]-N-propan-2-ylacetamide

2-[(3-cyano-4-phenyl-6-thiophen-2-yl-2-pyridinyl)thio]-N-propan-2-ylacetamide

C21H19N3OS2 (393.0969)


   

N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C20H15N3O6 (393.0961)


   

5-[[4-[(Z)-2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]furan-2-carboxylic acid

5-[[4-[(Z)-2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]furan-2-carboxylic acid

C22H16FNO5 (393.1012)


   

2-chloro-4-[[(1R)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile

2-chloro-4-[[(1R)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile

C20H16ClN5O2 (393.0992)


   

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

C18H19NO9 (393.106)


   

2-[2-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

2-[2-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

C18H19NO9 (393.106)


   

5-methoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazol-6-ol

5-methoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazol-6-ol

C22H19NO4S (393.1035)


   

(2r)-2-[(2r)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

(2r)-2-[(2r)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

C18H19NO9 (393.106)